Failure of pyridoxine to reduce drug-induced dyskinesias.
نویسندگان
چکیده
The use of pyridoxine seems to be ineffective in reducing tardive dyskinesia.
منابع مشابه
Chronic dialysis, NAT2 polymorphisms, and the risk of isoniazid-induced encephalopathy – case report and literature review
BACKGROUND Isoniazid is the most widely used anti-tuberculosis agent, yet it may lead to life-threatening complications. CASE PRESENTATION Here we report the case of a chronic hemodialysis patient who developed severe encephalopathy after the start of isoniazid. Blood levels of isoniazid were elevated, and acetyl-isoniazid over isoniazid ratio was decreased 3 h after intake of the medication,...
متن کاملAnosognosia - for - dyskinesias in PD 1 Running head : ANOSOGNOSIA - FOR - DYSKINESIAS IN PD Why are some Parkinson ’ s disease patients unaware of their dyskinesias ? Paul
Objective: To test the hypothesis that anosognosia-for-dyskinesias in Parkinson’s disease (PD) results from a failure to detect discrepancies between intended and actual movement. Background: PD patients often complain of drug-induced dyskinesias (involuntary movements) less than their carers. This remarkable unawareness is an example of anosognosia (i.e., unawareness of deficits associated wit...
متن کاملImplanted reuptake-deficient or wild-type dopaminergic neurons improve ON l-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease
OFF-L-dopa dyskinesias have been a surprising side-effect of intrastriatal foetal ventral mesencephalic transplantation in patients with Parkinson's disease. It has been proposed that excessive and unregulated dopaminergic stimulation of host post-synaptic striatal neurons by the grafts could be responsible for these dyskinesias. To address this issue we transplanted foetal dopaminergic neurons...
متن کاملThe acute brain response to levodopa heralds dyskinesias in Parkinson disease
OBJECTIVE In Parkinson disease (PD), long-term treatment with the dopamine precursor levodopa gradually induces involuntary "dyskinesia" movements. The neural mechanisms underlying the emergence of levodopa-induced dyskinesias in vivo are still poorly understood. Here, we applied functional magnetic resonance imaging (fMRI) to map the emergence of peak-of-dose dyskinesias in patients with PD. ...
متن کاملMetoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
Metoclopramide is an antiemetic drug which occasionally produced acute dystonic reactions. Although known to interfere with central dopamine mechanisms, it is frequently used in Parkinson's disease to prevent levodopa-induced nausea and vomiting. In this study metoclopramide did not increase Parkinsonism or reduce levodopa-induced involuntary movements in patients with Parkinson's disease. Pimo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of neurology, neurosurgery, and psychiatry
دوره 33 4 شماره
صفحات -
تاریخ انتشار 1970